Navigation Links
Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator

Philadelphia, PA (PRWEB) July 14, 2014

Seven promising startup companies developing online, mobile and software solutions to healthcare problems have been accepted into the University City Science Center’s first Digital Health Accelerator (DHA).

The awardees were selected from a pool of 69 applicants via a multi-stage process. They include Biomeme, Fitly, Life Patch, Curbside Care, UE LifeSciences and two overseas companies—Keosys (from France) and Pulse InfoFrame (from Canada) —both of which will be establishing their U.S. presence in Philadelphia. These companies are developing technologies that range from devices for monitoring and diagnosing infectious disease, breast cancer, and neurological disorders, to software tools that help providers manage the delivery of healthcare to their patients more effectively and efficiently, as well as consumer apps for health and wellness.

DHA awardees will receive up to $50,000, professional mentorship, and introductions to a variety of key healthcare stakeholders including insurers, pharmaceutical companies, hospitals and research institutions located in the Greater Philadelphia region. During the 10-month program, the early-stage healthcare IT companies will become members of the newly launched Innovation Center @3401 (ic@3401)—a collaboration between the Science Center and Drexel University at 3401 Market Street in Philadelphia. The DHA will be co-located with DreamIt Ventures, from which two of the DHA companies, Biomeme and Fitly, graduated in 2013.

“The DHA is a win-win for both the participating companies and the Commonwealth of Pennsylvania,” says Science Center President and CEO Stephen S. Tang, Ph.D., MBA. “It is a testament to the Greater Philadelphia region’s growing prominence as a hub for health IT that these promising early-stage companies value access to the breadth of supportive resources and the strong local market. In turn, their innovative technologies will have a positive impact on the Commonwealth’s economy, and the health of its citizens.”

“Pennsylvania and particularly Philadelphia are the birthplace of American innovation,” said Pennsylvania Department of Community and Economic Development Secretary C. Alan Walker. “The Corbett administration is proud to partner with organizations like the University City Science Center and support initiatives like the DHA which continue to build on our heritage of helping to take dreams from an idea to a scientific breakthrough that changes the health of the world.”

Applications were reviewed by the DHA selection committee, which is comprised of individuals who represent the entire healthcare ecosystem, including payers, providers, pharmaceutical companies, hospitals, academia, investors, and more. In order to be accepted into the DHA, applicants had to have a product in prototype stage (or beyond) that was ready to be put into the hands of users. Applicants’ connectivity with local academic institutions and revenue potential was also considered.

“Philadelphia is a hub of healthcare excellence and offers the ideal setting for healthcare startup companies to pilot and commercialize their products,” says Ming Fang, Principal of the Healthcare deal team at Safeguard Scientifics (NYSE:SFE), and a participant on the DHA selection committee. “We are excited about the increased activity in the digital health space here in Greater Philadelphia area, and look forward to supporting the awardees to help make their dreams of improving healthcare a reality.”

The DHA is supported in part by funding from the Commonwealth of Pennsylvania’s Discovered in PA – Developed in PA (D2PA) program. The Corbett administration created the D2PA program to support the most creative and innovative projects and ideas that support the creation of new, family-sustaining jobs, the commercialization of new technologies and the implementation of new and innovative programs that support Pennsylvania’s entrepreneurial community while enhancing the commonwealth’s overall global competitiveness.

About the Science Center
The University City Science Center is a dynamic hub for innovation, entrepreneurship and technology development in the Greater Philadelphia region. It provides business incubation, programming, lab and office facilities, and support services for entrepreneurs, start-ups, and growing and established companies. The Science Center was the first, and remains the largest, urban research park in the United States. Since it was founded in 1963, graduate organizations and current residents of the University City Science Center’s Port business incubators have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually. For more information about the Science Center, go to To view the Science Center’s 2014 Annual Review go to:

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers
2. The Seven Types of Damage That Cause Age-Related Disease Released
3. Operation Walk Utah Observes the Season of Giving by Providing No-cost Total Hip and Knee Replacements to Seven Utah Patients
4. Seven States Decline to Comply With Obama’s Policy Change on Insurance Cancellations; AIS E-Alert Offers Full Analysis of States’ Reactions
5. Seven Helpful Tips For Preventing Back Pain In Those With Sedentary Jobs
6. Hispanic Federation Presents Seventh Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event
7. BenefitMall Identifies Seven Tips for Tipped Employees
8. Hispanic Health Coalition Presents Seventh Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event
9. Vet24seven™ App Brings Your Veterinarian to Your Mobile Device
10. The Concilio Presents Seventh Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event
11. Family Health Centers of San Diego Presents Seventh Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event
Post Your Comments:
(Date:11/25/2015)... ... , ... For the first time, Vitalalert is donating half of its earnings ... partnership between the two groups began in 2014 with Vitalalert pledging a portion of ... was founded in 1954 and is an international Christian-based health organization whose mission is ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... ser potential att använda SyMRI för att ... för patienter med multipel skleros (MS) eller ... SyntheticMR AB för att kunna använda SyMRI ... Med SyMRI kan man generera flera konstrastbilder ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: